Zobrazeno 1 - 10
of 11
pro vyhledávání: '"Lisa Marafetti"'
Autor:
Carlo Giorda, Roberta Picariello, Elisa Nada, Barbara Tartaglino, Lisa Marafetti, Giuseppe Costa, Roberto Gnavi
Publikováno v:
PLoS ONE, Vol 7, Iss 4, p e33839 (2012)
Despite the heightened awareness of diabetes as a major health problem, evidence on the impact of assistance and organizational factors, as well as of adherence to recommended care guidelines, on morbidity and mortality in diabetes is scanty. We iden
Externí odkaz:
https://doaj.org/article/163eea4888a74592ba7f05dae449349e
Autor:
Alessio Petrelli, Barbara Tartaglino, Roberto Gnavi, Elisa Nada, Roberta Picariello, Carlo Giorda, Giuseppe Costa, Lisa Marafetti
Publikováno v:
Nutrition, Metabolism and Cardiovascular Diseases. 24:717-724
Backgrounds and aims To compare direct costs of four different care models and health outcomes in adults with type 2 diabetes. Methods and results We used multiple independent data sources to identify 25,570 adults with type 2 diabetes residing in Tu
Autor:
Carlo Giorda, Roberto Gnavi, Elisa Nada, Giuseppe Costa, Roberta Picariello, Barbara Tartaglino, Lisa Marafetti
Publikováno v:
The Lancet Diabetes & Endocrinology. 2:111-115
Summary Background Previous studies have yielded conflicting results about the association between incretin therapies and acute pancreatitis. We aimed to compare the occurrence of acute pancreatitis in a population of patients with type 2 diabetes wh
Autor:
Andrea Picu, Emanuela Arvat, Ezio Ghigo, Rosaria De Iasio, Fabio Broglio, Uberto Pagotto, Lorenza Bonelli, Flavia Prodam, Lisa Marafetti, Roberta Giordano, Mauro Maccario, Renato Pasquali
Publikováno v:
European Journal of Endocrinology. 153:535-543
Objective: Ghrelin exerts a wide spectrum of endocrine and non-endocrine actions. The stomach is the major source of circulating ghrelin levels that are negatively associated with body mass, insulin and glucose levels. The role of glucocorticoids in
Autor:
Andrea Benso, Riccarda Granata, Lisa Marafetti, Mauro Papotti, Maria Angela Seardo, Ezio Ghigo, V. Martina, Barbara Lucatello, Fabio Broglio, Giampiero Muccioli
Publikováno v:
Seminars in Vascular Medicine. 4:107-114
Ghrelin, a 28-amino acid peptide mainly produced by the stomach, is a natural ligand of the type 1a growth hormone secretagogue receptor (GHS-R1a) that also binds synthetic peptidyl and nonpeptidyl GHSs. GHS-R1a and various GHS-R1a-related receptor s
Publikováno v:
Endocrine. 48(2)
Concerns raised by several animal studies, case reports, and pharmacovigilance warnings over incretin-based therapy potentially exposing type two diabetes patients to an elevated risk of pancreatitis have cast a shadow on the overall safety of this c
Autor:
Barbara Lucatello, Andrea Benso, S. E. Oleandri, Elena Capello, Lisa Marafetti, Mauro Maccario, Denis Rossato, Mirko Parasiliti Caprino, Ezio Ghigo, Isabella Tabaro
ObjectiveIn most cases of primary aldosteronism (PA), an adrenal aldosterone-secreting tumor cannot be reasonably proven, so these patients undergo medical treatment. Controversial data exist about the evolution of PA after medical therapy: long-term
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::24b172a4393aefd7333a070d425dcccb
http://hdl.handle.net/2318/101003
http://hdl.handle.net/2318/101003
Autor:
Piero Guida, Carlo Giorda, Concetta Suraci, Elisa Nada, Lisa Marafetti, Valeria Manicardi, Salvatore Gentile, Maria Franca Mulas
Publikováno v:
Acta diabetologica. 50(1)
The time to achieve good metabolic control after diagnosis is essential for type 2 diabetes patients because it can influence long-term prognosis. This study aimed to elucidate the predictive role of several clinical and organization factors in norma
Autor:
Giuseppe Costa, Barbara Tartaglino, Elisa Nada, Carlo Giorda, Roberta Picariello, Roberto Gnavi, Lisa Marafetti
Publikováno v:
PLoS ONE, Vol 7, Iss 4, p e33839 (2012)
PLoS ONE
PLoS ONE
Despite the heightened awareness of diabetes as a major health problem, evidence on the impact of assistance and organizational factors, as well as of adherence to recommended care guidelines, on morbidity and mortality in diabetes is scanty. We iden
Autor:
Roberto Gnavi, Lisa Marafetti, Barbara Tartaglino, Annalisa Alessiato, Fabiana Di Noi, Giuseppe Costa, Roberta Picariello, Carlo Giorda
Publikováno v:
BMJ Open
Objective The SAVOR TIMI–53 study reported a significant increase in the risk of hospitalisation for heart failure (HF) in patients treated with a DPP-4 inhibitor (DPP-4i) in comparison with placebo. A recent case-control study in part confirmed th